Vimarsana
Biggest News Aggregation in the World

Page 8 - Beckley Psytech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beckley Psytech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beckley Psytech Today - Breaking & Trending Today

The firms hoping to take psychedelic drugs mainstream - Vimarsana News

The firms hoping to take psychedelic drugs mainstream

Start-ups are tweaking psychedelic compounds to treat mental health conditions.

Source: bbc.com
The firms hoping to take psychedelic drugs mainstream - Vimarsana News

The firms hoping to take psychedelic drugs mainstream

Start-ups are tweaking psychedelic compounds to treat mental health conditions.

Source: yahoo.com
The firms hoping to take psychedelic drugs mainstream - Vimarsana News

The firms hoping to take psychedelic drugs mainstream

Start-ups are tweaking psychedelic compounds to treat mental health conditions.

Source: bbc.co.uk
Psychedelics startups counter stereotypes to bring hallucinogens into mental healthcare - Vimarsana News

Psychedelics startups counter stereotypes to bring hallucinogens into mental healthcare

Psychedelics startups want to transform mental healthcare. But first, they need to win over the skeptics and break the taboos.

First Patient Dosed in Beckley Psytech's Phase IIa Study of BPL-003 for Treatment Resistant Depression - Vimarsana News

First Patient Dosed in Beckley Psytech's Phase IIa Study of BPL-003 for Treatment Resistant Depression

BPL-003 is Beckley Psytech's patent-protected benzoate formulation of 5-MeO-DMT (also known as Mebufotenin) and is administered intranasally via an FDA-approved delivery device. The multi-centre